Angiogenesis Inhibitors, Vitamin C
In this video, Neil Riordan spends about 27 minutes speaking on "Angiogenesis Inhibitors, Vitamin C" at the 29th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Neil Riordan
NEIL RIORDAN, P.A. is the Founder of Aidan Incorporated and the Aidan Clinic in Tempe, AZ. He holds 5 U.S. and international patents and has 7 patents pending. Mr. Riordan has co-authored articles on High-Dose Vitamin C, Novel Angiogenesis Inhibitors and Immunotherapeutic Agents for cancer, published in prestigious medical journals including British Journal of Cancer, AntiCancer Research, Journal of Orthomolecular Medicine and Medical Hypotheses.
Mr. Riordan received his B.S. Degree in Physician Assistant Studies, magna cum laude, from Wichita State University, Kansas and his Master’s Degree in Physician Assistant Studies (P.A.) from the University of Nebraska School of Medicine, Omaha. He was the Senior Research Scientist and Project Manager for Project RECNAC at the Biocommunications Research Institute from 1989 through 1999.
At present, Mr. Riordan is a member of the American Society for Microbiology, Kansas Academy of Physician Assistants, American Academy of Physician Assistants, and the American Chemical Society. He also was a member of the International Society for Nutrition and Cancer in 1997.
Currently, Mr. Riordan is the President and CEO of Aidan Clinic and Aidan Incorporated and is responsible for the research and development of protocols and therapies used there. Aidan Clinic is a research-based facility providing comprehensive care for people with cancer. Aidan Incorporated product line includes the dietary supplements C-Statin, Imm-Kine, and IVC-Max. He can be contacted at (480) 466-8181 or e-mail at [email protected].
Transcription
Thank you very much.
I want to thank Lorraine and Norman for putting on a great conference here.
I've learned a heck a lot. I want to congratulate Dr. C.. That's a fantastic study. We do a lot of immune therapy at our at our clinic. And we're looking at some of those same parameters. And that's that's really a fantastic study for many of you. We're expecting my father to be here. I apologize. It's only me. My father went to Europe and couldn't make it. So Lorraine asked me to choose, stand in for him. I worked at the Center for the Improvement of Human Functioning, Wichita, Kansas, for 14 years, alongside my father. And we did a lot of research on immune therapies for cancer. We did research on vitamin C and cancer. We did research on angiogenesis, natural angiogenesis inhibitors. And today, I'm going to talk a little bit about only this slide.
Let me see if I can get it to move. There go.
Presently I am. I started a clinic in Arizona with Dr. Daniel Rubin and we treat people's immune systems, primarily people who have cancer. We use a variety of mechanisms. We just like John Boik has just mentioned and Dr. C, what we try to do is attack from various angles. And these are the five major mechanisms that we use. We try to inhibit new blood vessel growth angiogenesis. We try to induce pertussis. Now, that's either apoptosis or pertussis, depending on which coast you're from.
I'm in Arizona, so I'd go either way on it. We tried to induce cellular differentiation. We tried to induce direct side of toxicity. And we also tried to hop up the immune system. So that recognizes tumors.
And today, I only have half an hour, so I'm not going to speak on immune therapy. If you'd like more information on that, you can pick up a copy of Alternative Medicine magazine. And there's a real nice piece in there this month on what all we do at the Aydan Clinic in Arizona.
And I think Tom Claver, the editors here and you can pick up a copy of that at our booth, which is Buth 40. I'm just going to talk about and angiogenesis inhibition and the use of high dose vitamin C. And I'm I'm going to respectfully disagree with Mr. Boik on the vitamin C.. And I'll show you the evidence for that disagreement. My father started his research into vitamin C in the early 80s.
He had a patient come to him with renal cell carcinoma that had spread to his liver and spread to his mediastinum. The area around